Inventor
FANGER CHRISTOPHER
US29 patents
⚠️ This page may combine multiple inventors who share the name “FANGER CHRISTOPHER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HYDRA BIOSCIENCES INC
7 patentsUS7998980B2Aug 16, 2011
Compounds for modulating TRPV3 function
HYDRA BIOSCIENCES INC15 citations92
US7893260B2Feb 22, 2011
Substituted quinazolin-4-one compounds for antagonizing TRPV3 function
HYDRA BIOSCIENCES INC23 citations91
US7671061B2Mar 2, 2010
Methods and compositions for treating pain
HYDRA BIOSCIENCES INC27 citations91
US7803790B2Sep 28, 2010
Compounds for modulating TRPV3 function
HYDRA BIOSCIENCES INC12 citations83
US9181219B2Nov 10, 2015
Compounds of modulating TRPV3 function
HYDRA BIOSCIENCES INC5 citations82
US9815838B2Nov 14, 2017
Methods and compositions for treating pain
HYDRA BIOSCIENCES INC2 citations72
US9895356B2Feb 20, 2018
Methods and compositions for treating anxiety
HYDRA BIOSCIENCES INC0 citations49
CADENT THERAPEUTICS INC
6 patentsUS10973825B2Apr 13, 2021
Thienopyrimidinone NMDA receptor modulators and uses thereof
CADENT THERAPEUTICS INC6 citations84
US10626122B2Apr 21, 2020
Heteroaromatic NMDA receptor modulators and uses thereof
CADENT THERAPEUTICS INC8 citations84
US10500205B2Dec 10, 2019
Thienopyrimidinone NMDA receptor modulators and uses thereof
CADENT THERAPEUTICS INC10 citations84
US11541057B2Jan 3, 2023
Thienopyrimidinone NMDA receptor modulators and uses thereof
CADENT THERAPEUTICS INC1 citations73
US11236104B2Feb 1, 2022
Heteroaromatic NMDA receptor modulators and uses thereof
CADENT THERAPEUTICS INC4 citations73
US11274107B2Mar 15, 2022
NMDA receptor modulators and uses thereof
CADENT THERAPEUTICS INC3 citations70
MORAN MAGDALENE M
4 patentsUS8541423B2Sep 24, 2013
Methods and compositions for treating pain
MORAN MAGDALENE M11 citations91
US8389529B2Mar 5, 2013
Methods and compositions for treating asthma
MORAN MAGDALENE M11 citations91
US8178542B2May 15, 2012
Methods and compositions for treating pain
MORAN MAGDALENE M13 citations91
US8389546B2Mar 5, 2013
Compounds for modulating TRPV3 function
MORAN MAGDALENE M4 citations62
CHONG JAYHONG A
4 patentsUS9139573B2Sep 22, 2015
Methods and compositions for treating anxiety
CHONG JAYHONG A8 citations80
US9486455B2Nov 8, 2016
Compounds for modulating TRPV3 function
CHONG JAYHONG A2 citations62
US8916550B2Dec 23, 2014
Compounds for modulating TRPV3 function
CHONG JAYHONG A3 citations61
US8552009B2Oct 8, 2013
Substituted pyrimido 4.5-d pyrimidin-4-one compounds for modulating TRPV3 function
CHONG JAYHONG A2 citations61
NOVARTIS AG
4 patentsUS12358929B2Jul 15, 2025
NMDA receptor modulators and uses thereof
NOVARTIS AG0 citations62
US12162890B2Dec 10, 2024
Heteroaromatic NMDA receptor modulators and uses thereof
NOVARTIS AG0 citations62
US11648253B2May 16, 2023
Thienopyrimidinone NMDA receptor modulators and uses thereof
NOVARTIS AG0 citations62
US11807650B2Nov 7, 2023
NMDA receptor modulators and uses thereof
NOVARTIS AG1 citations59